Joyvié Health raises $1.04M to reinvent continence care

Jan de Vries · 2026-06-05

Joyvié Health, a UK-based startup, has closed its pre-Seed funding round at $1.04 million (€897k). The money will fuel their mission to redesign continence underwear from the ground up. Their goal? Slash stool-to-skin contact, protect skin integrity, and lighten the load for caregivers. The round includes an Innovate UK grant plus backing from HERmesa Angels, SyndicateRoom, Lavender Ventures, and several angel investors. ### A personal mission born from tragedy Founder Zoe Robson started Joyvié after her father, Fred, died in 2025. He was 77, fit, and sharp-minded when a late-stage pancreatic cancer diagnosis hit on Christmas Eve 2024. Eleven weeks later, he was gone. During those weeks, Fred lost bowel control and had to wear adult nappies. The problem? Feces trapped against skin causes breakdown — moisture, pathogens, and pH imbalance do damage that never fully heals. His skin deteriorated. His dignity eroded with every change. Ruth, Fred's wife and primary caregiver, carried an invisible burden that was impossibly heavy. "My parents didn't deserve that," says Zoe. "They were both at their most vulnerable — and the product meant to help them was making it worse. The skin breakdown, the shame, the loss of dignity, the weight on my mum. It wasn't from lack of care. It's a design failure."  ### A smarter design for a massive problem Faecal incontinence affects an estimated 656 million people globally. Yet the most common non-invasive solution hasn't changed in decades: nappies and pads. Joyvié's innovation is simple but powerful. Instead of trapping stool against skin, their underwear contains it in a disposable pouch right after excretion. Early tests show about 90% less stool-to-skin contact and changes that are roughly 70% faster.  ### Bigger trends in HealthTech funding Joyvié's round is part of a wave of HealthTech funding across the UK and Europe in 2026. In the UK: - Semble raised $40.3 million for its healthcare management platform - Evaro secured $24.4 million for NHS-licensed health services - JAAQ closed $17.4 million for enterprise partnerships - Calibre emerged from stealth with $3.2 million - Nul raised $975k for alcohol-dependence care In Europe: - Recare (Berlin) raised up to $42.9 million for AI hospital platforms - Patronus raised $12.8 million for senior-friendly smartwatches - Tucuvi raised $19.7 million for voice-AI nursing automation - Ditto (Rotterdam) raised $8.8 million for patient-friendly medical info - ShanX Medtech secured $27.8 million for antimicrobial-resistance diagnostics - MedVasc raised $2.5 million for anesthesia catheters Combined, that's over $200 million in related HealthTech funding this year. ### Why investors are paying attention "At Lavender Ventures, we are committed to backing founders addressing large, underserved markets with innovative solutions that can meaningfully improve people's lives," says Gail Armstrong of Lavender Ventures. "We believe the market is ripe for innovation, and Joyvié's approach has the potential to deliver significant benefits not only for individuals, but also for carers, healthcare systems, and the environment." ### What's next for Joyvié The company is on a mission to end the silent humiliation of faecal incontinence. Their product addresses a clear gap: a design that actually works for patients and caregivers alike. With fresh funding and a deeply personal story, Joyvié is poised to challenge an industry that's been stuck for decades.